S Veeraraghavan
Overview
Explore the profile of S Veeraraghavan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thappali S, Varanasi K, Veeraraghavan S, Vakkalanka S, Khagga M
Arzneimittelforschung
. 2012 Nov;
62(12):624-30.
PMID: 23138519
Dasatinib is a multi-kinase inhibitor that potently inhibits Bcr-Abl, Src family and platelet-derived growth factor receptor kinases. Methotrexate is an antimetabolite and antifolate drug. Clinical trials utilizing a combination of...
2.
Boddu S, Yamsani M, Potharaju S, Veeraraghavan S, Rajak S, Kuma S, et al.
Pharmazie
. 2009 Sep;
64(8):525-31.
PMID: 19746842
Drug efflux by intestinal P-glycoprotein (P-gp) is recognized as a significant biochemical barrier affecting oral absorption for a number of drugs apart from the cytochrome P450 3A enzyme. Various conflicting...
3.
Varanasi K, Potharaju S, Rajak S, Veeraraghavan S, Mallick P, Vakkalanka S
Methods Find Exp Clin Pharmacol
. 2008 Nov;
30(7):537-42.
PMID: 18985182
The aim of this study was to investigate the effect of pentoxifylline (PTX), an antiplatelet agent, on the pharmacokinetics of rosiglitazone (RSG) in rats. Pharmacokinetic parameters of RSG were determined...
4.
du Bois R, Kangesan I, Veeraraghavan S
Semin Respir Crit Care Med
. 2005 Aug;
24(2):205-12.
PMID: 16088540
Identifying genetic determinants of pulmonary fibrosis is at an early stage of evolution. It is now well recognized that "pulmonary fibrosis" covers a broad range of lung diseases including most...
5.
Veeraraghavan S, Renzoni E, Jeal H, Jones M, Hammer J, Wells A, et al.
Ann Rheum Dis
. 2004 Jul;
63(8):982-7.
PMID: 15249326
Objectives: To identify the immunodominant T cell epitopes of the topoisomerase I protein in patients with systemic sclerosis (SSc) and control subjects, using computational analysis software (TEPITOPE) and T cell...
6.
Veeraraghavan S, Latsi P, Wells A, Pantelidis P, Nicholson A, Colby T, et al.
Eur Respir J
. 2003 Sep;
22(2):239-44.
PMID: 12952254
Idiopathic pulmonary fibrosis (IPF), which has the histological pattern of usual interstitial pneumonia (UIP), is a progressive interstitial lung disease with a poor prognosis. Idiopathic interstitial pneumonias with a histological...
7.
Abdallah A, Sato H, Grutters J, Veeraraghavan S, Lympany P, Ruven H, et al.
Genes Immun
. 2003 Aug;
4(6):450-4.
PMID: 12944982
The aetiology of sarcoidosis is uncertain; current thinking implicates exposure of genetically susceptible hosts to environmental factors. The nuclear factor kappa B (NF-kappaB) family of transcription factors are critical regulators...
8.
Veeraraghavan S, Nicholson A, Wells A
Curr Opin Rheumatol
. 2001 Nov;
13(6):500-4.
PMID: 11698728
The recent American Thoracic Society/European Respiratory Society consensus classification of idiopathic interstitial pneumonia is equally applicable to pulmonary fibrosis associated with connective tissue disease. The most frequent histopathologic entities are...
9.
McGrath D, Foley P, Petrek M, Izakovicova-Holla L, Kolek V, Veeraraghavan S, et al.
Am J Respir Crit Care Med
. 2001 Jul;
164(2):197-201.
PMID: 11463587
Previous studies of the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene in sarcoidosis have revealed both ethnic heterogeneity of I/D frequencies and controversy surrounding the association between the...
10.
Lubman R, Zhang X, Zheng J, Ocampo L, Lopez M, Veeraraghavan S, et al.
Am J Physiol Lung Cell Mol Physiol
. 2000 Jul;
279(1):L183-93.
PMID: 10893217
We investigated expression of the alpha(3)-integrin subunit by rat alveolar epithelial cells (AECs) grown in primary culture as well as the effects of monoclonal antibodies with blocking activity against the...